The American laboratory Gilead has just set, on Tuesday, June 30, 2020, the price at which it wants to sell its new medicine against Covid-19. The Remdesivir will be worth 2,340 dollars or more than MAD 21,000, the bottle. Remember that this drug has been authorized “in emergency” for only one month in the USA and has not been subject to the usual controls. We are waiting for the next few days a marketing authorization for Europe.
Gilead said his drug is only intended for wealthy countries. The price appears to have been calculated based on hospital savings. In the United States a month of hospitalization can cost up to a million dollars in the case of the Coronavirus (not far from 10 million DH).